These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 15932816)

  • 21. Serum sertraline and N-desmethylsertraline levels in breast-feeding mother-infant pairs.
    Wisner KL; Perel JM; Blumer J
    Am J Psychiatry; 1998 May; 155(5):690-2. PubMed ID: 9585724
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Maternal fluoxetine treatment in the postpartum period: effects on platelet serotonin and plasma drug levels in breastfeeding mother-infant pairs.
    Epperson CN; Jatlow PI; Czarkowski K; Anderson GM
    Pediatrics; 2003 Nov; 112(5):e425. PubMed ID: 14595087
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Soluble P-selectin - a marker of platelet activation and vessel wall injury: increase of soluble P-selectin in plasma of patients with myocardial infarction, massive atherosclerosis and primary pulmonary hypertension].
    Semenov AV; Kogan-Ponomarev MIa; Ruda MIa; Komarov AL; Panchenko EP; Chazova IE; Mazurov AV
    Ter Arkh; 2000; 72(4):15-20. PubMed ID: 10833791
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Soluble VCAM-1 and E-selectin, but not ICAM-1 discriminate endothelial injury in patients with documented coronary artery disease.
    Semaan HB; Gurbel PA; Anderson JL; Muhlestein JB; Carlquist JF; Horne BD; Serebruany VL
    Cardiology; 2000; 93(1-2):7-10. PubMed ID: 10894900
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Platelet function defects and sertraline-induced bleeding: a case report.
    Strumia M; Guerrero F; Maurel-Ribes A; Garcia C; Payrastre B; Bagheri H
    Fundam Clin Pharmacol; 2020 Oct; 34(5):632-636. PubMed ID: 32125025
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heart rate variability in acute coronary syndrome patients with major depression: influence of sertraline and mood improvement.
    Glassman AH; Bigger JT; Gaffney M; Van Zyl LT
    Arch Gen Psychiatry; 2007 Sep; 64(9):1025-31. PubMed ID: 17768267
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Psychiatric characteristics associated with long-term mortality among 361 patients having an acute coronary syndrome and major depression: seven-year follow-up of SADHART participants.
    Glassman AH; Bigger JT; Gaffney M
    Arch Gen Psychiatry; 2009 Sep; 66(9):1022-9. PubMed ID: 19736359
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of single-dose sertraline on the hypothalamus-pituitary-adrenal system, autonomic nervous system, and platelet function.
    Ahrens T; Frankhauser P; Lederbogen F; Deuschle M
    J Clin Psychopharmacol; 2007 Dec; 27(6):602-6. PubMed ID: 18004127
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in antidepressant metabolism and dosing across pregnancy and early postpartum.
    Sit DK; Perel JM; Helsel JC; Wisner KL
    J Clin Psychiatry; 2008 Apr; 69(4):652-8. PubMed ID: 18426260
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Onset of major depression associated with acute coronary syndromes: relationship of onset, major depressive disorder history, and episode severity to sertraline benefit.
    Glassman AH; Bigger JT; Gaffney M; Shapiro PA; Swenson JR
    Arch Gen Psychiatry; 2006 Mar; 63(3):283-8. PubMed ID: 16520433
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of desmethylsertraline with sertraline as a monoamine uptake inhibitor in vivo.
    Fuller RW; Hemrick-Luecke SK; Littlefield ES; Audia JE
    Prog Neuropsychopharmacol Biol Psychiatry; 1995 Jan; 19(1):135-49. PubMed ID: 7535937
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The selective serotonin reuptake inhibitor sertraline: its profile and use in psychiatric disorders.
    MacQueen G; Born L; Steiner M
    CNS Drug Rev; 2001; 7(1):1-24. PubMed ID: 11420570
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coadministration of short-term zolpidem with sertraline in healthy women.
    Allard S; Sainati SM; Roth-Schechter BF
    J Clin Pharmacol; 1999 Feb; 39(2):184-91. PubMed ID: 11563412
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Partial compliance as determined from plasma levels of sertraline and its metabolite in depressed patients in primary care.
    Reis M; Akerblad AC; Ekselius L; von Knorring L
    J Clin Psychopharmacol; 2010 Dec; 30(6):746-8. PubMed ID: 21057244
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of sertraline on circulating markers of oxidative stress in depressed patients with chronic heart failure: a pilot study.
    Michalakeas CA; Parissis JT; Douzenis A; Nikolaou M; Varounis C; Andreadou I; Antonellos N; Markantonis-Kiroudis S; Paraskevaidis I; Ikonomidis I; Lykouras E; Kremastinos D
    J Card Fail; 2011 Sep; 17(9):748-54. PubMed ID: 21872145
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Simultaneous determination of human plasma levels of citalopram, paroxetine, sertraline, and their metabolites by gas chromatography-mass spectrometry.
    Eap CB; Bouchoux G; Amey M; Cochard N; Savary L; Baumann P
    J Chromatogr Sci; 1998 Jul; 36(7):365-71. PubMed ID: 9679303
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of CYP2C19 genotype on sertraline exposure in 1200 Scandinavian patients.
    Bråten LS; Haslemo T; Jukic MM; Ingelman-Sundberg M; Molden E; Kringen MK
    Neuropsychopharmacology; 2020 Feb; 45(3):570-576. PubMed ID: 31649299
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between enhanced soluble CD40 ligand and proinflammatory and prothrombotic states in major depressive disorder: pilot observations on the effects of selective serotonin reuptake inhibitor therapy.
    Leo R; Di Lorenzo G; Tesauro M; Razzini C; Forleo GB; Chiricolo G; Cola C; Zanasi M; Troisi A; Siracusano A; Lauro R; Romeo F
    J Clin Psychiatry; 2006 Nov; 67(11):1760-6. PubMed ID: 17196057
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of sertraline in relation to genetic polymorphism of CYP2C19.
    Wang JH; Liu ZQ; Wang W; Chen XP; Shu Y; He N; Zhou HH
    Clin Pharmacol Ther; 2001 Jul; 70(1):42-7. PubMed ID: 11452243
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the effects of sertraline and its metabolite desmethylsertraline on blockade of central 5-HT reuptake in vivo.
    Sprouse J; Clarke T; Reynolds L; Heym J; Rollema H
    Neuropsychopharmacology; 1996 Apr; 14(4):225-31. PubMed ID: 8924190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.